Similar articles

• Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.

  Keitel WA, Cate TR, Nino D, Huggins LL, Six HR, Quarles JM, Couch RB. Keitel WA, et al. J Infect Dis. 2001 Jan 15;183(2):329-332. doi: 10.1086/317926. Epub 2000 Dec 8. J Infect Dis. 2001. PMID: 11110645 Clinical Trial.
• [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].

  Lupulescu E, Ioniţă E, Botez D, Matepciuc M, Tabra ME, Tecu C, Alexandrescu V, Munţiu A. Lupulescu E, et al. Bacteriol Virusol Parazitol Epidemiol. 1997 Jan-Jun;42(1-2):110-2. Bacteriol Virusol Parazitol Epidemiol. 1997. PMID: 9235136 Romanian. No abstract available.
• Influenza vaccine 2005-2006.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2005 Oct 24;47(1220):85-7. Med Lett Drugs Ther. 2005. PMID: 16264371 No abstract available.
• Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.

  Belshe R, Lee MS, Walker RE, Stoddard J, Mendelman PM. Belshe R, et al. Expert Rev Vaccines. 2004 Dec;3(6):643-54. doi: 10.1586/14760584.3.6.643. Expert Rev Vaccines. 2004. PMID: 15606348 Review.
• Live attenuated influenza vaccine in children.

  Ambrose CS, Walker RE, Connor EM. Ambrose CS, et al. Semin Pediatr Infect Dis. 2006 Oct;17(4):206-12. doi: 10.1053/j.spid.2006.08.007. Semin Pediatr Infect Dis. 2006. PMID: 17055372 Review.